Endari® Receives Kuwaiti Marketing Authorization
/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that it has received Registration Approval...
Source: prnewswire.com
Page 4 - Sciences Press News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sciences Press. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sciences Press Today - Breaking & Trending Today
Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari®
/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...
Source: prnewswire.com
IN BETWEEN THE DARK AND THE LIGHT (Television/Society/Art: A Symposium)
This week, the editors revisit writer-artist Constance DeJong’s “In Between the Dark and the Light,” a piece published in January 1981 on “Television/Society/Art,” a symposium held at the Kitchen in New York City the prior autumn. DeJong’s Reader (Primary Information), an anthology of eighteen texts including out-of-print and unpublished works, is in bookstores now.Before the internet, television was of course the messiah-bogeyman of consequence, promising liberation via the democratic dissemination of information as it reinforced mass psychology and mores. With the participation ...
Source: artforum.com
Emmaus Life Sciences Announces Engagement of Strategic Business Relations and Professional Services Advisor
/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,...
Source: prnewswire.com
Emmaus Life Sciences Announces Launch of Full-Service Telehealth Solution
/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTQXC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,...
Source: prnewswire.com